FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2120366105> ?p ?o ?g. }

• W2120366105 endingPage "305" @default.
• W2120366105 startingPage "300" @default.
• W2120366105 abstract "Objectives To investigate the prognostic role of prostate-specific antigen (PSA) level and prostate volume (PV) for the need for benign prostatic hyperplasia (BPH)-related invasive therapy among patients initially treated with an alpha1-blocker or watchful waiting (WW) in real-life clinical practice. Methods Data were collected from 2264 consecutive patients with clinical BPH. Patients initially treated with an alpha1-blocker or WW were included in this study. They were stratified by baseline PSA level (less than 1.5, 1.5 to less than 3.0, 3.0 to 10.0 ng/mL) and PV (less than 30 and 30 to 200 cm3), and analyzed for the time to BPH-related invasive therapy. Results Of the 2264 patients, 389 treated with alpha1-blockers and 553 who chose WW were included. Across the PSA and PV strata, the alpha1-blocker group had worse symptoms, peak flow, postvoid residual urine volumes, and obstruction than did the WW group. Increasing PSA levels produced an increase in the 5-year cumulative risk of invasive treatment: 20%, 34%, and 44% in the alpha1-blocker and 8%, 9%, and 15% in the WW group for a PSA level of less than 1.5, 1.5 to less than 3.0, and 3.0 to 10.0 ng/mL, respectively. The hazard ratio for the highest compared with the lowest PSA strata was 2.8 for alpha1-blocker and 2.7 for WW patients. An increasing PV increased the 5-year cumulative risk from 21% to 35% in the alpha1-blocker group and 8% to 11% in the WW group. The hazard ratio for the large versus small prostates in the alpha1-blocker group was 1.8 and in the WW group was 1.0. Conclusions A higher PSA level and larger PV resulted in a greater risk of BPH-related invasive therapy that was more pronounced in the alpha1-blocker than in the WW patients. However, symptom severity, flow parameters, and obstruction grade may have contributed to the difference in risk between the two treatment groups." @default.
• W2120366105 created "2016-06-24" @default.
• W2120366105 creator A5000040964 @default.
• W2120366105 creator A5024919772 @default.
• W2120366105 creator A5045763456 @default.
• W2120366105 creator A5048906687 @default.
• W2120366105 creator A5067833255 @default.
• W2120366105 creator A5082495905 @default.
• W2120366105 creator A5091552522 @default.
• W2120366105 date "2005-02-01" @default.
• W2120366105 modified "2023-10-07" @default.
• W2120366105 title "Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting" @default.
• W2120366105 cites W1990894210 @default.
• W2120366105 cites W2009440132 @default.
• W2120366105 cites W2018009871 @default.
• W2120366105 cites W2019725795 @default.
• W2120366105 cites W2028240651 @default.
• W2120366105 cites W2029221012 @default.
• W2120366105 cites W2033346597 @default.
• W2120366105 cites W2070883023 @default.
• W2120366105 cites W2082709973 @default.
• W2120366105 cites W2084318739 @default.
• W2120366105 cites W2121759271 @default.
• W2120366105 cites W2123278711 @default.
• W2120366105 cites W2126104986 @default.
• W2120366105 cites W2148027243 @default.
• W2120366105 cites W2163303711 @default.
• W2120366105 cites W2164089139 @default.
• W2120366105 cites W2165635016 @default.
• W2120366105 doi "https://doi.org/10.1016/j.urology.2004.09.030" @default.
• W2120366105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15708042" @default.
• W2120366105 hasPublicationYear "2005" @default.
• W2120366105 type Work @default.
• W2120366105 sameAs 2120366105 @default.
• W2120366105 citedByCount "24" @default.
• W2120366105 countsByYear W21203661052012 @default.
• W2120366105 countsByYear W21203661052016 @default.
• W2120366105 countsByYear W21203661052017 @default.
• W2120366105 countsByYear W21203661052019 @default.
• W2120366105 crossrefType "journal-article" @default.
• W2120366105 hasAuthorship W2120366105A5000040964 @default.
• W2120366105 hasAuthorship W2120366105A5024919772 @default.
• W2120366105 hasAuthorship W2120366105A5045763456 @default.
• W2120366105 hasAuthorship W2120366105A5048906687 @default.
• W2120366105 hasAuthorship W2120366105A5067833255 @default.
• W2120366105 hasAuthorship W2120366105A5082495905 @default.
• W2120366105 hasAuthorship W2120366105A5091552522 @default.
• W2120366105 hasConcept C121608353 @default.
• W2120366105 hasConcept C126322002 @default.
• W2120366105 hasConcept C126894567 @default.
• W2120366105 hasConcept C207103383 @default.
• W2120366105 hasConcept C2776141087 @default.
• W2120366105 hasConcept C2776235491 @default.
• W2120366105 hasConcept C2776547966 @default.
• W2120366105 hasConcept C2777562237 @default.
• W2120366105 hasConcept C2779478474 @default.
• W2120366105 hasConcept C2780192828 @default.
• W2120366105 hasConcept C2781406297 @default.
• W2120366105 hasConcept C44249647 @default.
• W2120366105 hasConcept C71924100 @default.
• W2120366105 hasConceptScore W2120366105C121608353 @default.
• W2120366105 hasConceptScore W2120366105C126322002 @default.
• W2120366105 hasConceptScore W2120366105C126894567 @default.
• W2120366105 hasConceptScore W2120366105C207103383 @default.
• W2120366105 hasConceptScore W2120366105C2776141087 @default.
• W2120366105 hasConceptScore W2120366105C2776235491 @default.
• W2120366105 hasConceptScore W2120366105C2776547966 @default.
• W2120366105 hasConceptScore W2120366105C2777562237 @default.
• W2120366105 hasConceptScore W2120366105C2779478474 @default.
• W2120366105 hasConceptScore W2120366105C2780192828 @default.
• W2120366105 hasConceptScore W2120366105C2781406297 @default.
• W2120366105 hasConceptScore W2120366105C44249647 @default.
• W2120366105 hasConceptScore W2120366105C71924100 @default.
• W2120366105 hasIssue "2" @default.
• W2120366105 hasLocation W21203661051 @default.
• W2120366105 hasLocation W21203661052 @default.
• W2120366105 hasOpenAccess W2120366105 @default.
• W2120366105 hasPrimaryLocation W21203661051 @default.
• W2120366105 hasRelatedWork W2063042565 @default.
• W2120366105 hasRelatedWork W2163346038 @default.
• W2120366105 hasRelatedWork W2335425470 @default.
• W2120366105 hasRelatedWork W2354209970 @default.
• W2120366105 hasRelatedWork W2371422341 @default.
• W2120366105 hasRelatedWork W2377899455 @default.
• W2120366105 hasRelatedWork W2389718753 @default.
• W2120366105 hasRelatedWork W2400783631 @default.
• W2120366105 hasRelatedWork W2462851122 @default.
• W2120366105 hasRelatedWork W4244049578 @default.
• W2120366105 hasVolume "65" @default.
• W2120366105 isParatext "false" @default.
• W2120366105 isRetracted "false" @default.
• W2120366105 magId "2120366105" @default.
• W2120366105 workType "article" @default.